Company to Discuss Upcoming Phase 1/2 Study of Twice Per Year Treatment for AMD
Continue ReadingCategory: Picture Gallery
Akers Biosciences Announces Board Changes
Experienced directors with medical device and financial backgrounds to steer the Company through next phase of…
Continue Reading
New Look Vision Group Inc. to Hold Second Quarter 2017 Results Conference Call
MONTREAL, QUEBEC -- (Marketwired) -- 08/07/17 -- New Look Vision Group Inc. (TSX: BCI) ("New Look")…
Continue Reading
Freddie Mac Issues Dodd-Frank Stress Test Results
MCLEAN, VA -- (Marketwired) -- 08/07/17 -- Freddie Mac (OTCQB: FMCC) today issued the company--s stress…
Continue Reading
Polsinelli Represents FelCor in Two Multimillion Dollar Hotel Deals in New York
NEW YORK, NY -- (Marketwired) -- 08/07/17 -- Am Law 100 firm Polsinelli announced today it…
Continue Reading
Q Therapeutics Expands Board of Directors With Appointment of Dr. Tom Parks as Independent Member
Appointment Adds World Class Expertise in Neuro-Cellular Interactions and functions
Continue Reading
IDW Entertainment Introduces IDW Digital Studio — Next Generation Digital Entertainment
Pioneering Initiative Maximizes IDW Franchises Across Multiple Digital Platforms
Continue Reading
NEMUS Bioscience Announces Presentation of CBD-analogue (NB2222) Ocular Data at the AAPS 2017 Annual Meeting
Data shows NB2222 exhibits superior ocular bioavailability versus plant-derived CBD
Continue Reading
MTBC Declares Dividends on Non-Convertible Series A Cumulative Redeemable Perpetual Preferred Stock
SOMERSET, NJ -- (Marketwired) -- 08/07/17 -- (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of proprietary…
Continue Reading
Ritter Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business Update
LOS ANGELES, CA -- (Marketwired) -- 08/07/17 -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) ("Ritter Pharmaceuticals" or…
Continue Reading